Friday, June 18, 2021

Health

BioBiz: Amgen Inc received approval from The U.S. Food and Drug Administration for Lumakras

Amgen Inc received approval from the U.S. Food and Drug Administration for its cancer drug, Lumakras (sotorasib) as the first treatment for adult patients with non-small cell lung cancer whose tumors have a specific type of genetic...

BioBiz: Bristol Myers Squibb to Pay Up to $1.38 Billion to License Agenus’ Oncology Drug

Bristol Myers Squibb (BMS) will gain the global rights to Agenus’ investigational cancer drug, AGEN1777, in a deal worth up to $1.38 billion. Under the licensing agreement, BMS will spearhead development and commercialization of...

Johnson & Johnson Single-Shot COVID-19 Vaccinations to Resume in the U.S.

Johnson & Johnson COVID-19 single-shot vaccine will resume for all adults aged 18 years and older in the U.S., under Emergency Use Authorization, following a decision from the United States Centers for Disease Control (CDC) and Food...

BioBiz: Johnson & Johnson COVID-19 Vaccine stopped; Repertoire gets $189M infusion; Agenus presents clinical data; Solo-Dex launches and more

Both the FDA and Centers for Disease Control have decided to stop administering Johnson & Johnson’s Covid-19 vaccine after reviewing data involving six reported cases of a rare and severe type of blood clot in individuals in...

Former President Obama cheers on Joe Biden on 11th Anniversary of Affordable Care Act

Today, behind some democrats led cheers, the focus shifted towards how the rescue plan will help Americans save in regards to their health care.

World’s first oral vaccine to fight the pandemic in the works

Researchers may have a real shot at creating an oral COVID-19 vaccine, one that can protect against variants.  A pill can be self-administered anywhere, anytime providing access to those in remote locations and the most vulnerable who...

BioBiz: Pfizer and BioN Tech says 94% effective; Biohaven Pharma slapped by FDA with Kardashian ads

Citing data from Israel, Pfizer and BioNTech said their COVID-19 vaccine was 94% effective in preventing asymptomatic infection, but their announcement lacked key details. These new data build upon and confirm previously released data from the Israel Ministry of Health...

BioBiz: Merck to aid in COVID-19 vax production; Novavax eyes FDA filing for COVID-19 vax

Pharma giant, Merck is supporting efforts to expand the manufacturing capacity and supply of COVID-19 medicines and vaccines. The Biomedical Advanced Research and Development Authority (BARDA), a division of the Office of the Assistant Secretary for Preparedness...

Johnson & Johnson COVID-19 vaccine wins FDA approval for emergency use

 The U.S. Food and Drug Administration issued an emergency use authorization (EUA) for the third vaccine for the prevention of coronavirus disease 2019 (COVID-19) caused by severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2). The EUA allows the...

Studies: eNAMPT, an inflammation-regulatory protein is now tightly linked to COVID-19 deaths

Several recent publications have now highlighted the damaging role of proteins called extracellular nicotinamide phosphoribosyltransferase (eNAMPT) in COVID-19 infections. In a comprehensive report published in the high impact journal CELL, of over 5,000 proteins identified as perturbed in COVID-19...
- Advertisement -

Latest News

“Can’t Cancel Pride” relief benefit special draws out big names in entertainment

Kylie Minogue, Leslie Odom Jr., Olly Alexander from Years & Years and Yola will join previously announced performers Bebe...
- Advertisement -

BioBiz: Amgen Inc received approval from The U.S. Food and Drug Administration for Lumakras

Amgen Inc received approval from the U.S. Food and Drug Administration for its cancer drug, Lumakras (sotorasib) as the first treatment for...

Amazon signs agreement to Acquire MGM for $8.45 Billion

Amazon announced today that it will acquire the Metro Goldwyn Mayer’s (MGM) for $8.45 billion, significantly enhancing its online content strategy.

Oatly stock soars nearly 30 percent during the company’s public market

Shares of the oat milk brand Oatly soared nearly 30 percent during the company’s public market debut Thursday. The stock...

BioBiz: Bristol Myers Squibb to Pay Up to $1.38 Billion to License Agenus’ Oncology Drug

Bristol Myers Squibb (BMS) will gain the global rights to Agenus’ investigational cancer drug, AGEN1777, in a deal worth up to $1.38...